CHICAGO, Oct. 23, 2019 /PRNewswire/ -- Whoever wins the 2019 World Series, the Houston Astros and Washington Nationals each benefit from working with registered dietitian nutritionists who are experts in sports nutrition.

ATLANTA, Oct. 23, 2019 /PRNewswire/ -- Oct. 26 is National Prescription Drug Take Back Day—a day t

SAN DIEGO, Oct. 23, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, announced that the Company will have two presentations at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting on November 6-10, 2019 at the Gaylord National Convention Center in National Har

SOUTH PLAINFIELD, N.J., Oct. 23, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on October 18, 2019 it approved non-statutory stock options to purchase an aggregate of 144,150 shares of its common stock to 29 new employees.  The awards were made pursuant to the NASDAQ inducement grant exception as a comp

LYNN, Mass., Oct. 23, 2019 /PRNewswire/ -- Apothca, Inc. ("Apothca") is scheduled to open Lynn's first Adult-Use Marijuana Dispensary at 491 Lynnway, Lynn, Massachusetts 01905 on Saturday, October 26, 2019. This is Apothca's first adult-use marijuana dispensary in Ma

PALO ALTO, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition t

PALO ALTO, Calif., Oct. 23, 2019 /PRNewswire/ -- In an effort to expand the availability of adaptive radiotherapy to patients at its hospital, Amsterdam UMC has placed an order for six Varian Ethos™ therapy solutions. Ethos therapy is an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and effici

IRVINE, Calif., Oct. 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended September 30, 2019.

ST. LOUIS, Oct. 23, 2019 /PRNewswire/ -- PercayAI, a newly launched augmented intelligence software company that helps researchers develop new drugs more quickly and successfully, today announced i

PEN ARGYL, Pa., Oct. 23, 2019 /PRNewswire/ -- "It all started to unravel the night she lost her dress in Connecticut. In fact, that was the first time I felt needed. Truly needed. Mental illness is a tricky thing. It manifests itself differently depending on decades. And if the mentally ill make it through their twenties medicated im